A fundamental challenge for cystic fibrosis (CF) gene therapy is ensuring sufficient transduction of airway epithelial cells to achieve therapeutic correction. Vehicles such as lysophosphatidylcholine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback